4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-110530
Options or other derivatives
- Chief Executive Officer acquired 13,676 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Weis Holger Chief Executive Officer | 2025-08-18 | Grant or award · Employee Stock Option (right to buy) | +13,676 | 13,676 | D | ||
Loading xslF345X05/ownership.xml…